BARCLAYS PLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 86 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,067
-99.9%
2,332,719
+16.9%
0.00%
-66.7%
Q3 2022$3,132,000
+834.9%
1,995,651
+1097.7%
0.00%
Q2 2022$335,000
+183.9%
166,620
+227.6%
0.00%
Q1 2022$118,000
-96.6%
50,859
-93.3%
0.00%
-100.0%
Q4 2021$3,520,000
+239.1%
756,858
+456.6%
0.00%
Q3 2021$1,038,000
+153.2%
135,978
+221.4%
0.00%
Q2 2021$410,000
-76.4%
42,302
-79.8%
0.00%
-100.0%
Q1 2021$1,736,000
-23.2%
209,898
-36.6%
0.00%0.0%
Q4 2020$2,260,000
-43.5%
331,104
-7.7%
0.00%
-50.0%
Q3 2020$4,000,000
+65.8%
358,863
-6.6%
0.00%0.0%
Q2 2020$2,413,000
+517.1%
384,276
+81.1%
0.00%
Q1 2020$391,000
-45.4%
212,205
+0.2%
0.00%
Q4 2019$716,000
+249.3%
211,685
+121.5%
0.00%
Q3 2019$205,000
+2.0%
95,578
+26.7%
0.00%
Q2 2019$201,000
+30.5%
75,416
+132.5%
0.00%
Q1 2019$154,000
-38.2%
32,431
-68.7%
0.00%
Q4 2018$249,000
-30.6%
103,672
+27.2%
0.00%
Q3 2018$359,000
+34.5%
81,515
+119.8%
0.00%
Q2 2018$267,000
-50.8%
37,079
-64.9%
0.00%
Q1 2018$543,000
+29.6%
105,500
-4.2%
0.00%
Q4 2017$419,000
+705.8%
110,144
+258.8%
0.00%
Q3 2017$52,000
-3.7%
30,700
+13.7%
0.00%
Q2 2017$54,000
+800.0%
27,000
+1739.2%
0.00%
Q1 2017$6,000
+100.0%
1,468
+127.2%
0.00%
Q4 2016$3,000
-50.0%
646
-35.4%
0.00%
Q2 2014$6,0001,0000.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Oaktree Fund Advisors, LLC 66,000$503,00048.93%
SABBY MANAGEMENT, LLC 1,698,107$12,957,0001.75%
EMFO, LLC 233,008$1,778,0001.57%
swisspartners Ltd. 110,000$839,0000.65%
HERITAGE WEALTH MANAGEMENT, LLC 150,000$1,145,0000.41%
Donald L. Hagan, LLC 42,929$328,0000.19%
COLLECTIVE FAMILY OFFICE LLC 44,203$337,0000.14%
Spectrum Wealth Advisory Group, LLC 18,093$138,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 100,000$763,0000.13%
Cormorant Asset Management, LP 400,000$3,052,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders